Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Selinexor
Related studies linked through entity extraction aliases.
Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Selinexor (KPT-330) Plus FLAG-Ida for the Treatment of Relapsing/Refractory AML
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
- Status
- TERMINATED
- Phase
- PHASE2
SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]
- Status
- COMPLETED
- Phase
- PHASE3
Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Selinexor in Advanced Liposarcoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1